ORLANDO, Fla., Feb. 28 (GenomeWeb News) - Thermo Electron has licensed a new commercial version of ProSight PTM, a software developed by the University of Illinois for identifying and characterizing intact proteins and their post-translational modifications, GenomeWeb News has learned.
The software will be released in about six months, according to the software's lead developer, Neil Kelleher, who gave a presentation on ProSight PTM yesterday at the PITTCON conference. Kelleher is an assistant professor of chemistry at the
A non-commercial version of ProSight PTM software is currently available for free here. The commercial version will differ from the non-commercial version in the way it performs batch processing, said Kelleher.
In addition, the commercial version of ProSight PTM will include a new method of searching referred to as the biomarker search mode. In this mode, the software specifically searches for protein fragments found in blood and tries to match them with top-down mass-spectrometry data.
"The commercial grade will be a lot more robust in terms of speed and features," Kelleher said.
A representative of Thermo Electron said the company prefers not reveal details about the licensing agreement and costs for ProSight PTM until a later date.